Ming Zhang,Raffaele Ferrari,Maria Carmela Tartaglia,Julia Keith,Ezequiel I. Surace,Uri Wolf,Christine Sato,Mark Grinberg,Yan Liang,Zhengrui Xi,Kyle Dupont,Philip McGoldrick,Anna Weichert,Paul M. McKeever,Raphael Schneider,Michael D. McCorkindale,Claudia Manzoni,Rosa Rademakers,Neill R. Graff-Radford,Dennis W. Dickson,Joseph E. Parisi,Bradley F. Boeve,Ronald C. Petersen,Bruce L. Miller,William W. Seeley,John C. van Swieten,Jeroen van Rooij,Yolande Pijnenburg,Julie van der Zee,Christine Van Broeckhoven,Isabelle Le Ber,Vivianna Van Deerlin,EunRan Suh,Jonathan D. Rohrer,Simon Mead,Caroline Graff,Linn Oijerstedt,Stuart Pickering-Brown,Sara Rollinson,Giacomina Rossi,Fabrizio Tagliavini,William S. Brooks,Carol Dobson-Stone,Glenda M. Halliday,John R. Hodges,Olivier Piguet,Giuliano Binetti,Luisa Benussi,Roberta Ghidoni,Benedetta Nacmias,Sandro Sorbi,Amalia C. Bruni,Daniela Galimberti,Elio Scarpini,Innocenzo Rainero,Elisa Rubino,Jordi Clarimon,Alberto Lleo,Agustin Ruiz,Isabel Hernandez,Pau Pastor,Monica Diez-Fairen,Barbara Borroni,Florence Pasquier,Vincent Deramecourt,Thibaud Lebouvier,Robert Perneczky,Janine Diehl-Schmid,Jordan Grafman,Edward D. Huey,Richard Mayeux,Michael A. Nalls,Dena Hernandez,Andrew Singleton,Parastoo Momeni,Zhen Zeng,John Hardy,Janice Robertson,Lorne Zinman,Ekaterina Rogaeva

Abstract:The G4C2-repeat expansion in C9orf72 is the most common known cause of amyotrophic lateral sclerosis and frontotemporal dementia. The high phenotypic heterogeneity of C9orf72 patients includes a wide range in age of onset, modifiers of which are largely unknown. Age of onset could be influenced by environmental and genetic factors both of which may trigger DNA methylation changes at CpG sites. We tested the hypothesis that age of onset in C9orf72 patients is associated with some common single nucleotide polymorphisms causing a gain or loss of CpG sites and thus resulting in DNA methylation alterations. Combined analyses of epigenetic and genetic data have the advantage of detecting functional variants with reduced likelihood of false negative results due to excessive correction for multiple testing in genome-wide association studies. First, we estimated the association between age of onset in C9orf72 patients (n = 46) and the DNA methylation levels at all 7603 CpG sites available on the 450 k BeadChip that are mapped to common single nucleotide polymorphisms. This was followed by a genetic association study of the discovery (n = 144) and replication (n = 187) C9orf72 cohorts. We found that age of onset was reproducibly associated with polymorphisms within a 124.7 kb linkage disequilibrium block tagged by top-significant variation, rs9357140, and containing two overlapping genes (LOC101929163 and C6orf10). A meta-analysis of all 331 C9orf72 carriers revealed that every A-allele of rs9357140 reduced hazard by 30% (P = 0.0002); and the median age of onset in AA-carriers was 6 years later than GG-carriers. In addition, we investigated a cohort of C9orf72 negative patients (n = 2634) affected by frontotemporal dementia and/or amyotrophic lateral sclerosis; and also found that the AA-genotype of rs9357140 was associated with a later age of onset (adjusted P = 0.007 for recessive model). Phenotype analyses detected significant association only in the largest subgroup of patients with frontotemporal dementia (n = 2142, adjusted P = 0.01 for recessive model). Gene expression studies of frontal cortex tissues from 25 autopsy cases affected by amyotrophic lateral sclerosis revealed that the G-allele of rs9357140 is associated with increased brain expression of LOC101929163 (a non-coding RNA) and HLA-DRB1 (involved in initiating immune responses), while the A-allele is associated with their reduced expression. Our findings suggest that carriers of the rs9357140 GG-genotype (linked to an earlier age of onset) might be more prone to be in a pro-inflammatory state (e.g. by microglia) than AA-carriers. Further, investigating the functional links within the C6orf10/LOC101929163/HLA-DRB1 pathway will be critical to better define age-dependent pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.

DNA methylation age-acceleration is associated with disease duration and age at onset in C9orf72 patients

A C6orf10/LOC101929163 Locus is Associated with Age of Onset in C9orf72 Carriers.

DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients

Genome-wide DNA methylation analysis related to ALS patient progression and survival

Epigenetic Clock Acceleration is Linked to Age at Onset of Parkinson's Disease

The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients

Combined epigenetic/genetic study identified an ALS age of onset modifier.

Epigenome-wide DNA methylation study of whole blood in patients with sporadic amyotrophic lateral sclerosis

DNA methylation age acceleration is associated with incident cognitive impairment in the Health and Retirement Study

Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression.

Genetic Variants Near MLST8 and DHX57 Affect the Epigenetic Age of the Cerebellum

Mitochondrial D-loop methylation levels inversely correlate with disease duration in amyotrophic lateral sclerosis

DNA methylation age is not accelerated in brain or blood of subjects with schizophrenia

Epigenetic age acceleration is associated with occupational exposures, sex, and survival in amyotrophic lateral sclerosis

Symmetric dimethylation of poly-GR correlates with disease duration in C9orf72 FTLD and ALS and reduces poly-GR phase separation and toxicity

Genome-wide study of DNA methylation in Amyotrophic Lateral Sclerosis identifies differentially methylated loci and implicates metabolic, inflammatory and cholesterol pathways

Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers

Comprehensive analysis of epigenetic clocks reveals associations between disproportionate biological ageing and hippocampal volume

Distinct CSF biomarker-associated DNA methylation in Alzheimer's disease and cognitively normal subjects

pTDP-43 levels correlate with cell type specific molecular alterations in the prefrontal cortex of ALS/FTD patients

Genetic and Epigenetic Study of an Alzheimer's Disease Family with Monozygotic Triplets.